Ratings by Rodman & Renshaw (Michael G. King, Jr)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/23/2026 Zentalis Pharmaceuticals ZNTL New Coverage Buy
(N/A)
4.50
(4.92)
9.33% Details